| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
27,480,000 |
| Market
Cap: |
56.61(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.29 - $2.27 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Synthetics |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Dyadic International is a global biotechnology platform company and it utilizes a number of third-party consultants and research organizations to carry out its activities. Co. has developed a gene expression platform for producing commercial quantities of enzymes and other proteins. This technology is based on the Thermothelomyces heterothallica fungus, which Co. named C1. The C1-cell protein production platform is a versatile thermophilic filamentous fungal expression system for the development and production of biologic products including enzymes and other proteins.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
8,943 |
| Total Sell Value |
$0 |
$0 |
$0 |
$31,202 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Francisco Trust Under Agreement Dated February 28, |
10% Owner |
– – • |
2021-08-11 |
4 |
S |
$770,984.00 |
$2,147,483,647 |
D/D |
(150,000) |
3,548,528 |
|
17% |
|
| Francisco Trust Under Agreement Dated February 28, |
10% Owner |
– – • |
2021-07-27 |
4 |
S |
$103,965.00 |
$2,147,483,647 |
D/D |
(25,000) |
3,698,528 |
|
13% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-09 |
4 |
OE |
$1.67 |
$167,000 |
I/I |
100,000 |
4,334,917 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-09 |
4 |
S |
$3.72 |
$85,560 |
I/I |
(23,000) |
4,234,917 |
|
-31% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-08 |
4 |
S |
$3.82 |
$114,600 |
I/I |
(30,000) |
4,257,917 |
|
-35% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-07 |
4 |
S |
$3.95 |
$173,800 |
I/I |
(44,000) |
4,287,917 |
|
-36% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-04 |
4 |
OE |
$1.67 |
$668,000 |
I/I |
400,000 |
4,331,917 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-04 |
4 |
S |
$3.85 |
$508,200 |
I/I |
(132,000) |
3,931,917 |
|
-37% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-03 |
4 |
S |
$3.61 |
$96,463 |
I/I |
(26,721) |
4,063,917 |
|
-48% |
|
| Rawson Ping Wang |
Chief Financial Officer |
• • – |
2021-06-03 |
4 |
B |
$3.60 |
$11,952 |
I/I |
3,320 |
9,650 |
1.99 |
48% |
|
| Rawson Ping Wang |
Chief Financial Officer |
• • – |
2021-06-03 |
4 |
B |
$3.60 |
$4,860 |
D/D |
1,350 |
35,850 |
2.66 |
48% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-06-02 |
4 |
S |
$3.74 |
$285,545 |
I/I |
(76,349) |
4,090,638 |
|
-40% |
|
| Rawson Ping Wang |
Chief Financial Officer |
• • – |
2021-06-02 |
4 |
B |
$3.83 |
$24,254 |
I/I |
6,330 |
6,330 |
1.99 |
40% |
|
| Rawson Ping Wang |
Chief Financial Officer |
• • – |
2021-06-02 |
4 |
B |
$3.70 |
$59,200 |
D/D |
16,000 |
34,500 |
2.74 |
40% |
|
| Herbst Seth |
Director |
• • – |
2021-01-29 |
4 |
OE |
$1.93 |
$96,500 |
D/D |
50,000 |
50,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-12-11 |
4 |
AS |
$5.80 |
$26,535 |
D/D |
(4,575) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-12-11 |
4 |
OE |
$1.41 |
$6,451 |
D/D |
4,575 |
10,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-12-10 |
4 |
AS |
$5.84 |
$31,682 |
D/D |
(5,425) |
4,575 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-12-10 |
4 |
OE |
$1.41 |
$7,649 |
D/D |
5,425 |
5,425 |
|
- |
|
| Buckland Barry |
Director |
– • – |
2019-12-03 |
4 |
S |
$6.18 |
$92,700 |
D/D |
(15,000) |
0 |
|
- |
|
| Buckland Barry |
Director |
– • – |
2019-12-03 |
4 |
OE |
$1.39 |
$20,850 |
D/D |
15,000 |
15,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-11-11 |
4 |
AS |
$5.99 |
$59,900 |
D/D |
(10,000) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-11-11 |
4 |
OE |
$1.41 |
$14,100 |
D/D |
10,000 |
10,000 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-10-11 |
4 |
AS |
$6.08 |
$31,725 |
D/D |
(5,218) |
0 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• – – |
2019-10-11 |
4 |
OE |
$1.41 |
$7,357 |
D/D |
5,218 |
5,218 |
|
- |
|
103 Records found
|
|
Page 2 of 5 |
|
|
0.17 (7.62%) 
